BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Treatment
1743 results:

  • 1. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
    Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
    Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
    Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Common misconceptions and myths about ovarian cancer causation: a national cross-sectional study from palestine.
    Elshami M; Jaber I; Alser M; Al-Slaibi I; Jabr H; Ubaiat S; Tuffaha A; Khader S; Khraishi R; Arafeh ZA; Al-Madhoun S; Alqattaa A; Yaseen A; El Hadi AA; Barhoush O; Hijazy M; Eleyan T; Alser A; Hziema AA; Shatat A; Almakhtoob F; Mohamad B; Farhat W; Abuamra Y; Mousa H; Adawi R; Musallam A; Albarqi SI; Abu-El-Noor N; Bottcher B
    BMC Public Health; 2024 Apr; 24(1):1027. PubMed ID: 38609950
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Blood leukocytes as a non-invasive diagnostic tool for thyroid nodules: a prospective cohort study.
    Wang F; Zhao D; Xu WY; Liu Y; Sun H; Lu S; Ji Y; Jiang J; Chen Y; He Q; Gong C; Liu R; Su Z; Dong Y; Yan Z; Liu L
    BMC Med; 2024 Apr; 22(1):147. PubMed ID: 38561764
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Small-molecule inhibitor HI-TOPK-032 improves NK-92MI cell infiltration into ovarian tumours.
    Deng M; Yang R; Sun Q; Zhang J; Miao J
    Basic Clin Pharmacol Toxicol; 2024 May; 134(5):629-642. PubMed ID: 38501576
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: A systematic review and network meta-analysis of randomized controlled trials.
    Huan L; Yu F; Cao D; Zhou H; Qin M; Cao Y
    PLoS One; 2024; 19(3):e0295983. PubMed ID: 38451955
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A clinicopathological study about the epidemiology of granulosa cell tumors in Lebanon.
    Yaacoub S; Hajj L; Khairallah A
    BMC Cancer; 2024 Mar; 24(1):309. PubMed ID: 38448917
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diagnosis and treatment of patients with suspected mucinous cystic neoplasms of the liver: a retrospective cohort study.
    Furumaya A; Schulz HH; Verheij J; Takkenberg RB; Besselink MG; Kazemier G; Erdmann JI; van Delden OM
    Langenbecks Arch Surg; 2024 Feb; 409(1):66. PubMed ID: 38368313
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Assessing Adequacy: A Meta-Analysis of Rapid Onsite Evaluation of Thyroid Nodules.
    Issa PP; McCarthy C; Hussein M; Albuck AL; Emad E; Shama M; Moroz K; Toraih E; Kandil E
    J Surg Res; 2024 Apr; 296():523-531. PubMed ID: 38330678
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Platinum desensitization therapy and its impact on the prognosis of ovary high-grade serous adenocarcinoma: a real world-data.
    Li K; Yin R
    Front Immunol; 2024; 15():1346464. PubMed ID: 38312839
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer].
    Xu D; Tu M; Zhang K; Wu PF; Lyu N; Wang QQ; Yin J; Wu Y; Lu ZP; Chen JM; Xi CH; Wei JS; Guo F; Miao Y; Jiang KR
    Zhonghua Wai Ke Za Zhi; 2024 Feb; 62(2):147-154. PubMed ID: 38310383
    [No Abstract]    [Full Text] [Related]  

  • 12. Modeling health outcomes associated with BRCA testing and treatment strategies for patients with metastatic pancreatic cancer.
    Agnihotri N; Ambavane A; Fan L; Li W; Yoo H; Joo S; Muston D
    Pancreatology; 2024 Mar; 24(2):271-278. PubMed ID: 38286712
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
    Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
    Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Perioperative and long-term survival outcomes of pancreatectomy with arterial resection in borderline resectable or locally advanced pancreatic cancer following neoadjuvant therapy: a systematic review and meta-analysis.
    Xue K; Huang X; Zhao P; Zhang Y; Tian B
    Int J Surg; 2023 Dec; 109(12):4309-4321. PubMed ID: 38259002
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The comparison of functional status and health-related parameters in ovarian cancer survivors with healthy controls.
    Gultekin SC; Cakir AB; Guc ZG; Ozalp FR; Keskinkilic M; Yavuzsen T; Yavuzsen HT; Karadibak D
    Support Care Cancer; 2024 Jan; 32(2):119. PubMed ID: 38252310
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Radiofrequency ablation for papillary thyroid microcarcinoma with a trachea-adjacent versus trachea-distant location.
    Jing H; Yan L; Xiao J; Li X; Jiang B; Yang Z; Li Y; Sun B; Zhang M; Luo Y
    Int J Hyperthermia; 2024; 41(1):2270671. PubMed ID: 38214143
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors.
    How JA; Legarreta AF; Handley KF; Fellman B; Foster KI; Glassman D; Vuttaradhi VK; Brodsky AL; Lawson B; Frumovitz M; Westin SN; Ramondetta LM; Gershenson DM; Sood AK; Hillman RT
    Am J Obstet Gynecol; 2024 May; 230(5):544.e1-544.e13. PubMed ID: 38191019
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer.
    Khanmammadov NJ; Doğan İ; Okay NS; Azizy A; Saip P; Aydiner A
    Medicine (Baltimore); 2024 Jan; 103(1):e36750. PubMed ID: 38181291
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2).
    Farnes I; Kleive D; Verbeke CS; Aabakken L; Issa-Epe A; Småstuen MC; Fosby BV; Dueland S; Line PD; Labori KJ
    BJS Open; 2023 Nov; 7(6):. PubMed ID: 38155512
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response.
    Tamaki A; Kato T; Sakurai Y; Sato K; Adachi K; Tadehara M; Kogami T; Matsushita M; Hoshino A; Sanoyama I; Numata Y; Umezawa A; Ichinoe M; Ichihara M; Kusano C; Murakumo Y
    Cancer Sci; 2024 Feb; 115(2):660-671. PubMed ID: 38130032
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 88.